##plugins.themes.bootstrap3.article.main##

PT. ABCD has faced the issue of legacy facilities that become findings in routine inspections of NRA. The issue can be escalated to shut down the production facility due to the legacy facility hardly complying with cGMP. The study aims to choose the best alternatives of building a new facility, renovating the current facility, and toll manufacturing with consideration of financial, regulation compliance, project completion speed, and strategy risk. The study is using Analytic Hierarchy Process (AHP) to get a decision from the experts in PT. ABCD. The respondents are seven experts in many fields, including finance, project management, GMP, operations, demand forecasting, technological transfer, business development, cGMP engineering, and the management representative. To analyze the group decision-making, the results of each respondent are aggregated with a geometric mean. Compliance with regulation (0.356) was found to be the top priority, followed by strategy risk (0.295), project completion speed (0.250), and financial aspect (0.098). Results show that (a) building a new facility (0.4563) is the best alternative among the other alternatives, followed by toll manufacturing (0.3251) and renovating the current facility (0.2186); and (b) building a new facility is the best alternative among the other alternatives (0.4563) followed by toll manufacturing (0.3251) and renovating current facility (0.2186) with consideration of criteria financial aspect, regulation aspect, project completion speed aspect, and strategy risk aspect. We recommend implementing the project plan to build a new facility.

Downloads

Download data is not yet available.

References

  1. Arruñada, B., & Våzquez, H. X. (2006). When your contract manufacturer becomes your competitor. Harvard Business Review.
     Google Scholar
  2. Dolgui, A., & Proth, J.-M. (2013). Outsourcing: Definitions and analysis. International Journal of Production Research, 51(23-24), 6769-6777.
     Google Scholar
  3. Han, C., Porterfield, T., & Li, X. (2012). Impact of industry competition on contract manufacturing: An empirical study of U.S. manufacturers. International Journal of Production Economics, 138(1), 159-169.
     Google Scholar
  4. Kramer, L., & Ward, T. (2018, December 10). Aging facilities to new technologies: The regulatory impact on GMP manufacturing facilities and product licensed applications [Presentation]. International Society of Pharmaceutical Engineering, California, CA, United States.
     Google Scholar
  5. Mahoney, R., Francis, D. P., Frazatti-Gallina, N. M., Precioso, A. R., Raw, I., Watler, P., Whitehead, P., & Whitehead, S. S. (2012). Cost of production of live attenuated dengue vaccines: A case study of the Instituto Butantan, Sao Paulo, Brazil. Vaccine, 30(32), 4892-4896.
     Google Scholar
  6. NNE-Novo Nordisk Engineering. (2017, May 25). What closed systems mean for bioprocessing facility design. https://www.nne.com/techtalk/what-closed-systems-mean-for-bioprocessing-facility-design.
     Google Scholar
  7. Pharmaceutical Inspection Co-operation Scheme. (2021). Guide to good manufacturing practice for medicinal products annexes. Pharmaceutical Inspection Convention.
     Google Scholar
  8. Plotkin, S., Robinson, J. M., Cunningham, G., Iqbal, R., & Larsen, S. (2017). The complexity and cost of vaccine manufacturing – An overview. Vaccine, 35(33), 4064-4071.
     Google Scholar
  9. PT. ABCD. (2022). Annual report 2021 (Report).
     Google Scholar
  10. Public Relations Cabinet Secretariat of the Republic of Indonesia. (2022). Presiden resmikan pabrik vaksin COVID-19 berbasis mRNA pertama di Asia Tenggara [Indonesia president officially open the first mRNA based Covid-19 vaccine facility in Southeast Asia]. https://setkab.go.id/presiden-resmikan-pabrik-vaksin-covid-19-berbasis-mrna-pertama-di-asia-tenggara/.
     Google Scholar
  11. Robinson, J. M. (2016). Vaccine production: Main steps and considerations. In P.-H. Lambert & B. R. Bloom (Eds.), The vaccine book (pp. 77 - 96). Elsevier.
     Google Scholar
  12. Saaty, T. L. (2008). Decision making with the analytic hierarchy process. International Journal Services Sciences, 1(1), 83-98.
     Google Scholar
  13. Shahsavarani, A. M., & Abadi, E. A. (2015). The bases, principles, and methods of decision-making: A review of literature. International Journal of Medical Reviews, 2(1), 214-225.
     Google Scholar
  14. Taherdoost, H., & Madanchian, M. (2023). Multi-criteria decision making (MCDM) methods and concepts. Encyclopedia, 3(1), 77-87.
     Google Scholar
  15. Vaidya, O. S., & Kumar, S. (2006). Analytic hierarchy process: An overview of applications. European Journal of Operational Research, 169(1), 1-29.
     Google Scholar
  16. Wiederseim, W. B., Felicia, A., & Kline, S. (2005). Facility planning. In A. A. Signore, & T. Jacobs (Eds.), Good design practices for GMP pharmaceutical facilities (pp. 41-54). Taylor & Francis.
     Google Scholar
  17. World Health Organization. (2011). Annex 6: WHO good manufacturing practices for sterile pharmaceutical products (Technical Report Series No. 961). https://www.who.int/docs/default-source/medicines/norms-and-standards/guidelines/production/trs961-annex6-gmp-sterile-pharmaceutical-products.pdf.
     Google Scholar